SCHEMBL26548183

SCHEMBL26548183

C[Si](C)(C)c1ccc(-c2ccc3cc(-c4ccc(-c5cccc6ccccc56)nc4)ccc3c2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 5/20 0.40
CYP11B2 P19099 5/20 0.40
CA12 O43570 3/20 0.39
CA9 Q16790 3/20 0.39
PIM1 P11309 1/20 0.39
ENPP1 P22413 2/20 0.39
ENPP3 O14638 1/20 0.39
CYP2C9 P11712 2/20 0.38
CYP2C19 P33261 2/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2B6 P20813 1/20 0.38
CYP17A1 P05093 1/20 0.36
CYP19A1 P11511 1/20 0.36
CA1 P00915 2/20 0.36
CA2 P00918 2/20 0.36
KDM4E B2RXH2 1/20 0.36
ALDH1A1 P00352 1/20 0.36
HPGD P15428 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26548697 0.96 CYP11B1 (0.39) CYP11B1CYP11B2CA12CA9PIM1
SCHEMBL26549203 0.92 CA12 (0.38) CYP11B1CYP11B2CA12CA9PIM1
SCHEMBL26564770 0.88 CYP11B1 (0.44) CYP11B1CYP11B2CA12CA9PIM1
SCHEMBL26564751 0.87 CYP11B1 (0.44) CYP11B1CYP11B2CA12CA9PIM1
SCHEMBL26547945 0.85 ENPP1 (0.49) CYP11B1CYP11B2CA12CA9PIM1
SCHEMBL26548385 0.85 ENPP1 (0.49) CYP11B1CYP11B2CA12CA9PIM1
SCHEMBL26551572 0.84 PIM1 (0.41) CYP11B1CYP11B2CA12CA9PIM1
SCHEMBL26548180 0.84 L3MBTL1 (0.46) CYP11B1CYP11B2CA12CA9PIM1
SCHEMBL26551585 0.84 BMX (0.43) CYP11B1CYP11B2CA12CA9PIM1
SCHEMBL26548178 0.84 CYP11B1 (0.45) CYP11B1CYP11B2CYP2C9CYP2C19CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230337527-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME LAPTO CO., LTD. (KR) 2023-10-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230337527-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME AOC1, ODC1, PIEZO1 CYP11B1 1676/4885CYP11B2 1913/4885CA12 807/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.